SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test

Symptoms related to COVID-19 infections can be confused with those of Influenza or even a common cold. A rapid test with differentiated detection of the multiple pathogens will reduce times and uncertainty on the initial screening of patients.

Retail price

0.0

Yuan

Market price

0.0

Yuan

Number of views:

1000

Product serial number

Category

COVID-19 Total Solution

Quantity

Stock:



Product description

Clinical Evaluation

1.SARS-CoV-2 & Influenza A/B Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method) is used as a control reagent. A
total of 577 samples were included in this study. The following results were obtained:

2. The Influenza A Virus Antigen Detection Reagent (Colloidal Gold Method) was used as a control reagent. A total of 437
samples were included in this study. The following results were obtained:

3.The Influenza B Virus Antigen Detection Reagent (Colloidal Gold Method) was used as the control reagent. A total of 437
samples were included in this study. The following results were obtained: